SCHEMBL8042850

SCHEMBL8042850

CCOC(=O)c1c(CC)nc(-c2ccc(C)cc2)[nH]c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 3/20 0.47
HPGD P15428 2/20 0.47
GAA P10253 1/20 0.47
ADORA3 P0DMS8 2/20 0.46
TSHR P16473 2/20 0.44
HSD17B10 Q99714 2/20 0.44
USP2 O75604 1/20 0.44
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MAPT P10636 1/20 0.44
CASP1 P29466 1/20 0.44
TARBP2 Q15633 1/20 0.43
TNKS O95271 3/20 0.43
PARP1 P09874 3/20 0.43
TNKS2 Q9H2K2 3/20 0.43
TRPM8 Q7Z2W7 1/20 0.42
SIRT2 Q8IXJ6 2/20 0.42
SIRT1 Q96EB6 1/20 0.42
SIRT3 Q9NTG7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8036853 0.90 SIRT2 (0.54) ALDH1A1ADORA3TSHRHSD17B10USP2
SCHEMBL8032162 0.81 SIRT2 (0.52) ALDH1A1TSHRHSD17B10USP2MAPK1
SCHEMBL4017101 0.80 TSHR (0.43) ALDH1A1KDM4EHPGDGAATSHR
SCHEMBL8762855 0.78 HSD17B10 (0.52) ALDH1A1KDM4EHPGDGAAADORA3
SCHEMBL8026733 0.77 SIRT2 (0.56) ALDH1A1KDM4EHPGDGAATSHR
SCHEMBL7216561 0.75 ADORA3 (0.60) ALDH1A1KDM4EHPGDGAAADORA3
SCHEMBL22712554 0.75 USP2 (0.48) ALDH1A1KDM4EHPGDGAAADORA3
SCHEMBL8022429 0.73 SIRT2 (0.52) ALDH1A1TSHRHSD17B10USP2MAPK1
SCHEMBL8040651 0.73 ADORA3 (0.47) ALDH1A1KDM4EHPGDGAAADORA3
SCHEMBL22712539 0.72 HSD17B10 (0.46) ALDH1A1KDM4EHPGDGAAADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080242-A1 SUBSTITUTED 4-AMINOPYRIMIDINE-5-CARBOXYLIC ACID AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-02 WO disclosed